AU4841799A - Methods and pharmaceutical formulations for preventing and treating motion sickness - Google Patents
Methods and pharmaceutical formulations for preventing and treating motion sicknessInfo
- Publication number
- AU4841799A AU4841799A AU48417/99A AU4841799A AU4841799A AU 4841799 A AU4841799 A AU 4841799A AU 48417/99 A AU48417/99 A AU 48417/99A AU 4841799 A AU4841799 A AU 4841799A AU 4841799 A AU4841799 A AU 4841799A
- Authority
- AU
- Australia
- Prior art keywords
- preventing
- methods
- pharmaceutical formulations
- motion sickness
- treating motion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9111498P | 1998-06-29 | 1998-06-29 | |
US60091114 | 1998-06-29 | ||
PCT/US1999/014657 WO2000000193A1 (en) | 1998-06-29 | 1999-06-29 | Methods and pharmaceutical formulations for preventing and treating motion sickness |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4841799A true AU4841799A (en) | 2000-01-17 |
Family
ID=22226169
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU48417/99A Abandoned AU4841799A (en) | 1998-06-29 | 1999-06-29 | Methods and pharmaceutical formulations for preventing and treating motion sickness |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU4841799A (en) |
WO (1) | WO2000000193A1 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040265238A1 (en) * | 2003-06-27 | 2004-12-30 | Imtiaz Chaudry | Inhalable formulations for treating pulmonary hypertension and methods of using same |
US9138228B2 (en) | 2004-08-11 | 2015-09-22 | Emory University | Vascular conduit device and system for implanting |
US7846123B2 (en) | 2007-04-24 | 2010-12-07 | Emory University | Conduit device and system for implanting a conduit device in a tissue wall |
EP2667792B1 (en) | 2011-01-28 | 2020-05-06 | Apica Cardiovascular Limited | Systems for sealing a tissue wall puncture |
US9320875B2 (en) | 2011-02-01 | 2016-04-26 | Emory University | Systems for implanting and using a conduit within a tissue wall |
WO2014117087A1 (en) | 2013-01-25 | 2014-07-31 | Apica Cardiovascular Limited | Systems and methods for percutaneous access, stabilization and closure of organs |
EP2968717A4 (en) | 2013-03-15 | 2017-02-22 | Apk Advanced Medical Technologies, Inc. | Devices, systems, and methods for implanting and using a connnector in a tissue wall |
US10485909B2 (en) | 2014-10-31 | 2019-11-26 | Thoratec Corporation | Apical connectors and instruments for use in a heart wall |
AU2021254780A1 (en) * | 2020-04-16 | 2022-10-20 | Atossa Therapeutics, Inc. | Compositions and methods to reduce the infectivity of a virus |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4749700A (en) * | 1984-10-23 | 1988-06-07 | Nastech Pharmaceutical Co, Inc. | Novel methods of administering antihistamines, antinausea and antiemetic pharmaceutical agents and novel dosage forms containing same |
-
1999
- 1999-06-29 WO PCT/US1999/014657 patent/WO2000000193A1/en active Application Filing
- 1999-06-29 AU AU48417/99A patent/AU4841799A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2000000193A1 (en) | 2000-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL131201A0 (en) | Pharmaceutical formulations comprising amoxocyllin and clavulanate | |
SG79255A1 (en) | Pharmaceutical formulations | |
IL127559A0 (en) | Compounds and methods for providing pharmacologically active preparations and uses thereof | |
AU5565099A (en) | Pharmaceutical compositions and methods for use | |
NZ513650A (en) | Pharmaceutical composition for the treatment of urinary incontinence, motion sickness and vertigo | |
IL211081A0 (en) | Methods and devices for providing prolonged drug therapy | |
AU3472799A (en) | Dermatological formulations and methods | |
AU4841799A (en) | Methods and pharmaceutical formulations for preventing and treating motion sickness | |
CY2293B1 (en) | Slow-release pharmaceutical formulations containing mizolastin | |
AUPP672198A0 (en) | Pyrazolopyridine compound and pharmaceutical use thereof | |
GB9818927D0 (en) | Pharmaceutical formulation | |
EP0987942A4 (en) | Pharmaceutical composition and methods for using it | |
EP1142589A4 (en) | Medicinal preparations | |
IL136635A0 (en) | Pharmaceutical formulations and processes for their preparation | |
AU2880699A (en) | Pharmaceutical compositions and methods for use | |
GB9822333D0 (en) | Pharmaceutical formulation | |
GB9817470D0 (en) | Pharmaceutical formulation | |
IL137076A0 (en) | Bibapctitide-based pharmaceutical compositions for imaging and treating thrombi | |
GB9615710D0 (en) | Pharmaceutical preparations for the treatment of sarcocystosis | |
ZA9811105B (en) | Cosmetic and pharmaceutical composition | |
GB9802617D0 (en) | Pharmaceutical formulation | |
HUP0001584A3 (en) | Pharmaceutical formulations comprising amoxocyllin and clavulanate | |
GB9802681D0 (en) | Pharmaceutical compoations for imaging and treating thrombi | |
AU9173298A (en) | Methods and compositions for medical imaging | |
GB9816558D0 (en) | Pharmaceutical formulations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |